Outcome of Combined Temozolomide/CCNU versus Temozolomide (Standard or Extended) For Patients with Methylated MGMT Glioblastoma. (2026). Journal of Cancer Research Updates, 15(3), 197-205. https://doi.org/10.30683/1929-2279.2026.15.18